Regions Financial Corp Emergent Bio Solutions Inc. Transaction History

Regions Financial Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$39.92 - $53.86 $225,987 - $304,901	-5,661 Closed	0 $0
Q1 2019 Apr 19, 2019	BUY	$48.23 - $66.16 $8,054 - $11,048	167 Added 3.04%	5,661 $286,000
Q4 2018 Jan 28, 2019	SELL	$55.63 - $73.24 $98,798 - $130,074	-1,776 Reduced 24.43%	5,494 $326,000
Q3 2018 Oct 22, 2018	SELL	$52.05 - $66.51 $12,960 - $16,560	-249 Reduced 3.31%	7,270 $479,000
Q2 2018 Jul 26, 2018	SELL	$48.33 - $55.64 $96,998 - $111,669	-2,007 Reduced 21.07%	7,519 $380,000
Q1 2018 Apr 18, 2018	SELL	$44.44 - $54.39 $139,008 - $170,131	-3,128 Reduced 24.72%	9,526 $501,000
Q4 2017 Jan 18, 2018	SELL	$37.77 - $47.75 $472,313 - $597,113	-12,505 Reduced 49.7%	12,654 $588,000
Q3 2017 Oct 23, 2017	BUY	$34.14 - $40.45 $858,928 - $1.02 Million	25,159	25,159 $1.02 Million

158

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $561M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Regions Financial Corp with notifications on news.